Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

492 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liquid biopsy: the value of different bodily fluids.
Santos V, Freitas C, Fernandes MG, Sousa C, Reboredo C, Cruz-Martins N, Mosquera J, Hespanhol V, Campelo R. Santos V, et al. Among authors: mosquera j. Biomark Med. 2022 Feb;16(2):127-145. doi: 10.2217/bmm-2021-0370. Epub 2022 Jan 25. Biomark Med. 2022. PMID: 35073730 Review.
10(th) Congress on Lung Cancer-updates on clinical trials: goal.
Campelo RG, Massuti B, Mosquera J, Rosell R. Campelo RG, et al. Among authors: mosquera j. Transl Lung Cancer Res. 2014 Apr;3(2):66-9. doi: 10.3978/j.issn.2218-6751.2014.02.05. Transl Lung Cancer Res. 2014. PMID: 25806282 Free PMC article. Review.
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
Antolín S, García-Caballero L, Reboredo C, Molina A, Mosquera J, Vázquez-Boquete Á, Gallego R, Santiago MP, Concha Á, Pérez E, Calvo L, García-Caballero T. Antolín S, et al. Among authors: mosquera j. Virchows Arch. 2021 Oct;479(4):853-857. doi: 10.1007/s00428-021-03104-7. Epub 2021 May 1. Virchows Arch. 2021. PMID: 33934230 Review.
Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?
Antolín S, García-Caballero L, Reboredo C, Molina A, Mosquera J, Vázquez-Boquete Á, Gallego R, Santiago MP, Concha Á, Pérez E, Calvo L, García-Caballero T. Antolín S, et al. Among authors: mosquera j. Virchows Arch. 2021 Oct;479(4):859. doi: 10.1007/s00428-021-03121-6. Virchows Arch. 2021. PMID: 34117906 No abstract available.
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.
Antolín S, Acea B, Albaina L, Concha Á, Santiago P, García-Caballero T, Mosquera JJ, Varela JR, Soler R, Calvo L. Antolín S, et al. Among authors: mosquera jj. Breast Cancer (Dove Med Press). 2018 Dec 27;11:29-42. doi: 10.2147/BCTT.S179750. eCollection 2019. Breast Cancer (Dove Med Press). 2018. PMID: 30643452 Free PMC article.
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial.
Sierra-Rodero B, Cruz-Bermúdez A, Nadal E, Garitaonaindía Y, Insa A, Mosquera J, Casal-Rubio J, Dómine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Massuti B, Laza-Briviesca R, Casarrubios M, García-Grande A, Romero A, Franco F, Provencio M. Sierra-Rodero B, et al. Among authors: mosquera j. J Immunother Cancer. 2021 Aug;9(8):e002804. doi: 10.1136/jitc-2021-002804. J Immunother Cancer. 2021. PMID: 34446577 Free PMC article.
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.
Provencio M, Rodríguez-Abreu D, Ortega AL, Serrano G, Aguado C, Franco F, Gutierrez V, López Vivanco G, Guirado M, Benítez G, Estival A, Calvo V, Jiménez B, Arasanz H, Coves J, Majem M, Massutí B, Vázquez S, Juan-Vidal O, Collazo-Lorduy A, Gozálvez CL, Del Barco E, Rosero A, Bosch-Barrerra J, Moreno MA, Mielgo-Rubio X, Villa JC, López-Martin A, Córdoba JF, de Asís Aparisi F, Zafra M, Mosquera J, Pérez Altozano J, Nadal E, Catot S, Balsalobre J, de Portugal T, Martín P, Cuesta de Juan S, Cobo M. Provencio M, et al. Among authors: mosquera j. Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504. Transl Lung Cancer Res. 2022. PMID: 35242627 Free PMC article.
492 results